| Basic and clinical aspects of BOTOX. | |
| | |
MedLine Citation:
|
PMID: 19341758 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BOTOX is a botulinum toxin type A product from Allergan that is approved in more than 70 countries, where it addresses unmet patient needs across a variety of indications. BOTOX is a well-characterized and highly purified biological product that is not interchangeable with any other botulinum neurotoxin. The pharmacology, efficacy and safety profile of BOTOX has been established in numerous preclinical and clinical studies in addition to meta-analyses. BOTOX exhibits a predictable response, with a concomitant low rate of neutralizing antibody formation. Allergan is committed to the development of new indications and novel biologics that are designed to benefit individuals with unmet medical needs. |
| | |
Authors:
|
Mitchell F Brin |
Related Documents
:
|
21356418 - Alcoholism: a modern look at an ancient illness. 21539738 - The potential for bi-lateral agreements in medical tourism: a qualitative study of stak... 21176978 - Criminal activities of the elderly in turkey during the years 2000-2005. 21355428 - Vitamin c: ascerbic ethical discussions. 10327508 - Return to work after surgery for lumbar disc herniation. a rehabilitation-oriented appr... 1203188 - Comparative study of hebrew university-hadassah medical school participation in educati... |
Publication Detail:
|
Type: Journal Article Date: 2009-03-31 |
Journal Detail:
|
Title: Toxicon : official journal of the International Society on Toxinology Volume: 54 ISSN: 1879-3150 ISO Abbreviation: Toxicon Publication Date: 2009 Oct |
Date Detail:
|
Created Date: 2009-08-24 Completed Date: 2009-12-11 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 1307333 Medline TA: Toxicon Country: England |
Other Details:
|
Languages: eng Pagination: 676-82 Citation Subset: IM |
Affiliation:
|
Allergan, LLC, 2525 Dupont Dr., Irvine, CA 92623-9534, USA. brin_mitchell@allergan.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Botulinum Toxin Type A
/
chemistry*,
classification,
isolation & purification,
therapeutic use* Drug Industry* Humans Neuromuscular Agents / chemistry*, classification, isolation & purification, therapeutic use* |
| Chemical | |
Reg. No./Substance:
|
0/Botulinum Toxin Type A; 0/Neuromuscular Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Purification, characterization and cytotoxicity of malanin, a novel plant toxin from the seeds of Ma...
Next Document: The effect of eccentricity on the contrast response function of multifocal visual evoked potentials ...